Tenon Medical
NASDAQ: TNON $6.83 USD
Tenon Medical is a medical device company developing the Catamaran SI-Joint Fusion System, a titanium implant that transfixes the sacroiliac joint along its longitudinal axis through an inferior-posterior approach, for the treatment of sacroiliac joint disorders causing severe lower back pain. Incorporated in 2012, headquartered in Los Gatos, California, and listed on Nasdaq in April 2022, the company is a microcap commercial-stage surgical devices name; in August 2026 it announced a 1-for-35 reverse stock split as its share price traded below $0.20.
Company Info
Sector:Medical Devices / Spine & SI Joint
Headquarters:Los Gatos, California, USA
Founded:2012
Website:www.tenonmed.com/
Upcoming Milestones & Key Dates
August 2026
Corporate Action
1-for-35 reverse stock split implementation following shareholder approval
Clinical Development Pipeline
Catamaran SI-Joint Fusion System
Target: Titanium SI-joint fusion implant (inferior-posterior approach)Recent News
No recent news updates available for this company.
Leadership Team
Steven M. Foster
Chief Executive Officer and President
Richard M. Ferrari
Founder and Executive Chairman